Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care
Open Access
- 25 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-7
- https://doi.org/10.1038/s41598-021-84328-0
Abstract
Wiskott Aldrich syndrome (WAS) is a rare disease and hematopoietic stem cell transplant (HCT) is considered the treatment modality of choice for WAS. We conducted a cross-sectional analysis on the KIDS’ pediatric inpatient database and compared hospitalization rates, complications and healthcare utilizations in the transplant and non-transplant arms. Of the 383 pediatric admissions with diagnosis of WAS between 2006–2012, 114 underwent transplant and 269 did not. The non-transplant arm included older children, female patients and more African Americans. Death rates, income and payer source were similar in both arms, however the total charge for each admission was higher in the transplant arm. Emergency room visits were similar but non-elective admissions were more in the non-transplant arm. Length of stay was prolonged in the transplant arm. When comparing morbidities, lymphomas, ulcerative colitis and autoimmune complications of WAS were seen only in the non-transplant arm. Our study shows that transplant is the largest contributor to healthcare utilization in WAS patients. We identified healthcare disparities based on race and socioeconomic status and found that this rare disease is being appropriately directed to centers with HCT expertise. We noted a change in practice moving away from splenectomy in WAS patients.This publication has 39 references indexed in Scilit:
- Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large National Private Claims DatabaseBone Marrow Transplantation, 2012
- Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative studyBlood, 2011
- Wiskott-Aldrich Syndrome: Diagnosis, Clinical and Laboratory Manifestations, and TreatmentTransplantation and Cellular Therapy, 2009
- Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow TransplantationBlood, 2008
- Comparison of Self-Report, Hospital Discharge Codes, and Adjudication of Cardiovascular Events in the Women's Health InitiativeAmerican Journal of Epidemiology, 2004
- Clinical course of patients with WASP gene mutationsBlood, 2004
- X-Linked Wiskott–Aldrich Syndrome in a GirlThe New England Journal of Medicine, 1998
- Random X chromosome inactivation in a female with a variant of Wiskott‐Aldrich syndromeBritish Journal of Haematology, 1995
- A multiinstitutional survey of the Wiskott-Aldrich syndromeThe Journal of Pediatrics, 1994
- Complete Correction of the Wiskott-Aldrich Syndrome by Allogeneic Bone-Marrow TransplantationThe New England Journal of Medicine, 1978